Yabao Pharmaceutical Group Co., Ltd (SHSE: 600351)
Health Care · Pharmaceuticals · CN
CN¥6.82
+2.25% today · +3.0% 1Y
Yabao Pharmaceutical Group Co., Ltd (SHSE: 600351) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $703.57M and employs 3,415 people.
Over the last twelve months the share price has gained 3.0%, trading between 5.60 and 7.45.
Tweenvest scores Yabao Pharmaceutical Group Co., Ltd across four factors: quality 80/100, value 69/100, growth 44/100, dividend 73/100. Its strongest factor is quality.
600351 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $703.57M
- Revenue (TTM)
- $330.59M
- P/E
- 14.65
- EPS
- 0.47
- Dividend yield
- 4.40%
- Beta (5Y)
- 0.04
- 52-week high
- CN¥7.45
- 52-week low
- CN¥5.60
- Avg volume (3M)
- —
- Shares outstanding
- 692.00M
- Employees
- 3,415
- Next earnings
- —
About Yabao Pharmaceutical Group Co., Ltd
Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Beijing, China.
- ISIN
- CNE000001CM5
- Founded
- 1978
- Listed since
- Sep 26, 2002
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Collegium Pharmaceutical, Inc.NasdaqGS: COLL | $711.99M | $21.88 | +0.05% |
| Knight Therapeutics Inc.TSX: GUD | $711.14M | CA$10.55 | +2.23% |
| Oneness Biotech Co., Ltd.TPEX: 4743 | $709.73M | NT$47.15 | +5.36% |
| Nxera Pharma Co., Ltd.TSE: 4565 | $706.80M | ¥1,220.00 | -3.17% |
| China Shineway Pharmaceutical Group LimitedSEHK: 2877 | $701.77M | HK$7.29 | -0.34% |
| Mochida Pharmaceutical Co., Ltd.TSE: 4534 | $690.86M | ¥3,090.00 | -6.36% |
| Fuan Pharmaceutical (Group) Co., Ltd.SZSE: 300194 | $689.94M | CN¥3.89 | +1.30% |
| ChengDa Pharmaceuticals Co., Ltd.SZSE: 301201 | $688.50M | CN¥30.49 | +1.13% |
Figures last refreshed Oct 4, 2026.